Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model

Intravenous (IV) topotecan is approved for the treatment of various malignancies including lung cancer but its clinical use is greatly undermined by severe hematopoietic toxicity. We hypothesized that inhalation delivery of topotecan would increase local exposure and efficacy against lung cancer whi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Deliv
Asıl Yazarlar: Kuehl, Philip J., Grimes, Marcie J., Dubose, Devon, Burke, Michael, Revelli, David A., Gigliotti, Andrew P., Belinsky, Steven A., Tessema, Mathewos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058531/
https://ncbi.nlm.nih.gov/pubmed/29779406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1469688
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller